Lucid Diagnostics Executes First Direct Employer Contract to Provide EsoGuard® Esophageal Precancer Testing as an Employee BenefitPRNewsWire • 08/24/23
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 15, 2023PRNewsWire • 07/31/23
Lucid Diagnostics to Present at the Canaccord Genuity 43rd Annual Growth ConferencePRNewsWire • 07/26/23
PAVmed and Lucid Chairman and Chief Executive Officer, Dr. Lishan Aklog, Testifies at U.S. House of Representatives Energy and Commerce Committee, Hearing on Life-Saving Innovations and Medicare CoveragePRNewsWire • 07/19/23
Lucid Diagnostics and Collaborators Present New EsoGuard® and EsoCheck® Data at Digestive Disease Week® (DDW) 2023 ConferencePRNewsWire • 05/11/23
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 16, 2023PRNewsWire • 05/05/23
Lucid Diagnostics Reports Publication of Future Effective Foundational Local Coverage Determination by Medicare Administrative Contractor Noridian Healthcare SolutionsPRNewsWire • 04/18/23
Lucid Diagnostics to Present at 22nd Annual Needham Virtual Healthcare ConferencePRNewsWire • 04/18/23
Lucid Diagnostics Provides Update on Newly Published Future Effective Medicare Local Coverage Determination on Molecular Testing for Detection of Esophageal Precancer and CancerPRNewsWire • 03/31/23
Lucid Diagnostics Provides Business Update and Fourth Quarter and Full Year 2022 Financial ResultsPRNewsWire • 03/13/23
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 14, 2023PRNewsWire • 03/03/23
Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic IndustryBusiness Wire • 12/08/22
Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer ResearchBusiness Wire • 12/01/22